- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity2008 | First Faculty of Medicine
- Glycogen phosphorylase BB as a marker of cardiac toxicity during hematopoietic cell transplantation in hematooncology2009 | First Faculty of Medicine
- Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia2013 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies2010 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB levels are associated with haemodynamic parameters in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt insertion2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity +12008 | Faculty of Medicine in Hradec Králové
- Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy2010 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB as a marker of cardiac toxicity during hematopoietic cell transplantation in hematooncology +12009 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation2007 | Publication without faculty affiliation
- Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation2007 | First Faculty of Medicine
- Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation +12007 | Faculty of Medicine in Hradec Králové
- The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia2010 | Faculty of Medicine in Hradec Králové
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia2008 | First Faculty of Medicine
- News in the field of cardiomarkers +12007 | Faculty of Medicine in Hradec Králové
- News in the field of cardiomarkers2007 | First Faculty of Medicine
- Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy2009 | Faculty of Medicine in Hradec Králové
- Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy2009 | First Faculty of Medicine
- New biomarkers of myocardial injury and assessment of cardiac toxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia2008 | First Faculty of Medicine
- Biochemical markers in the diagnostics of cardiovascular toxicity of hematooncology treatment in year 2008 +12008 | Faculty of Medicine in Hradec Králové
- Biochemical markers in the diagnostics of cardiovascular toxicity of hematooncology treatment in year 20082008 | First Faculty of Medicine
- Biomarkers of myocardial ischemia and necrosis in 2008 +12008 | Faculty of Medicine in Hradec Králové
- Biomarkers of myocardial ischemia and necrosis in 20082008 | First Faculty of Medicine
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia2008 | Faculty of Medicine in Hradec Králové